Peng Liu

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Venues

Cancer medicine

Annals of hematology

Cancer

British journal of haematology

Zhongshan Hospital Fudan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhongshan Hospital Fudan University

China

Head of Department of Hematology :: Department of Hematology

Publications

Jiadai Xu, Panpan Li, Yawen Wang, Jing Li, Bei Xu, Jiangyan Zhao, Chen Chen, Shiyang Gu, Chen Ding, Peng Liu
The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis. British journal of haematology (2024)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine (2023)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine 13 (1) (2023)
Liang Ren, Yuhong Ren, Yang Yang, Wenjing Wang, Tianhong Xu, Yawen Wang, Jiadai Xu, Aziguli Maihemaiti, Tianwei Lan, Panpan Li, Chi Zhou, Pu Wang, Peng Liu
Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Tianhong Xu, Yang Yang, Jing Li, Jiadai Xu, Wenjing Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Peng Liu
Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation. Annals of hematology (2023)
Yang Yang, Jing Li, Wenjing Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Xianmuseye Aihemaiti, Feifei Chen, Tianhong Xu, Jiadai Xu, Peng Liu
The evolving diagnosis and treatment paradigms of multiple myeloma in China: 15 years' experience of 1256 patients in a national medical center. Cancer medicine (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer 129 (7) (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer 129 (7) (2023)
Jing Li, Yang Yang, Wenjing Wang, Jiadai Xu, Yifeng Sun, Jifeng Jiang, Hui Tan, Liang Ren, Yue Wang, Yuhong Ren, Yian Zhang, Tianhong Xu, Xuebing Jia, Xiaoyun Huang, Peng Liu
Single-cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage-targeted strategy in multiple myeloma. British journal of haematology (2023)
Yawen Wang, Jiadai Xu, Panpan Li, Yanyan Xu, Hongwei Xue, Peng Liu
Zanubrutinib-lenalidomide-rituximab (ZR 2 ) in unfit diffuse large B-cell lymphoma: efficient and tolerant. Annals of hematology (2023)
Yue Wang, Jiadai Xu, Tianwei Lan, Chi Zhou, Peng Liu
The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity. Cancer medicine (2023)
Yawen Wang, Jiadai Xu, Bei Xu, Panpan Li, Yang Yang, Wenjing Wang, Tianhong Xu, Aziguli Maihemaiti, Tianwei Lan, Pu Wang, Liang Ren, Chi Zhou, Xianmuseye Aihemaiti, Peng Liu
The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse. Cancer 129 (7) (2023)
Jiadai Xu, Yawen Wang, Panpan Li, Chen Chen, Zhihong Jiang, Xiaona Wang, Peng Liu
PRUNE1 (located on chromosome 1q21.3) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion. British journal of haematology (2023)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine (2023)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine (2023)
Liang Ren, Tianhong Xu, Yuhong Ren, Peng Liu
The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset. Cancer medicine (2023)
Chuanxu Liu, Hao Ding, Qi Zhu, Peng Liu, Yang Zhu, Lifeng Wang, Yujie Ma, Wenhao Zhang, Shu Tian, Xiaoyan Zhang, Lina Jin, Ligen Liu, Zhichao Li, Siguo Hao, Rong Tao
Induction with MEDA regimen and consolidation with Auto-HSCT for stage IV NKTCL patients: A prospective multicenter study. International journal of cancer 151 (5) (2022)
Yawen Wang, Jiadai Xu, Jing Li, Zheng Wei, Miaojie Shi, Rong Tao, Bobin Chen, Yuyang Tian, Wenhao Zhang, Yan Ma, Lihua Sun, Yunhua Hou, Qilin Zhan, Jigang Wang, Hongwei Xue, Peng Liu
Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study. Annals of hematology 101 (10) (2022)
Zhao Xu, Yifeng Sun, Jifeng Jiang, Peng Liu
The role of KIAA1191 in the necroptotic pathway of multiple myeloma. Annals of hematology 101 (2) (2022)
Yi-An Zhang, Xue Yang, Jiamei Yao, Yuhong Ren, Peng Liu
Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics. Disease markers 2022 (2022)
Jing Li, Hui Tan, Tianhong Xu, Hongcheng Shi, Peng Liu
Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value. Annals of hematology 100 (12) (2021)
Jing Li, Li Bao, Zhongjun Xia, Sili Wang, Xin Zhou, Kaiyang Ding, Wenhao Zhang, Wei Yang, Bingzong Li, Chengcheng Fu, Bing Chen, Luoming Hua, Liang Wang, Jun Luo, Yang Yang, Tianhong Xu, Weida Wang, Yun Huang, Guolin Wu, Peng Liu
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study. Annals of hematology 99 (11) (2020)
Jiadai Xu, Jing Li, Zheng Wei, Yue Wang, Peng Liu
Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study. BMJ open 10 (9) (2020)
Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Jing Li, Yuhong Ren, Shiyang Gu, Chen Chen, Zheng Wei, Jingli Zhuang, Zhimei Wang, Lili Ji, Luya Cheng, Weiguang Wang, Zhixiang Cheng, Yang Ke, Ling Yuan, Peng Liu
The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides. Leukemia & lymphoma 61 (10) (2020)
Jiadai Xu, Zheng Wei, Yian Zhang, Chen Chen, Jing Li, Peng Liu
A Novel Scoring System Based on the Level of HDL-C for Predicting the Prognosis of t-DLBCL Patients: A Single Retrospective Study. BioMed research international 2018 (2018)

Peng Liu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peng Liu